
Toxic Nanoparticles w/ Dr Ana Mihalcea
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Guest Dr. Ana Mihalcea joins host Serge Brown in her third appearance on The Crash Cart Rule to discuss the C19 experimental shot that is delivering Toxic Nanoparticles into every one of the 69.7% of the planet who has received this sudo vaccine. Are these 5.35 billion people who have been given this shot at risk of imminent death or damage within the next few years from blood clots, myocarditis, strokes, aggressive forms of cancer, Guillain-Barre syndrome, transverse myelitis, Bell’s palsy, vaccine-induced immune thrombotic thrombocytopenia, vaccine-induced prothrombotic immune thrombotic thrombocytopenia or any of the other adverse effects that have been reported to the CDC's Vaccine Adverse Event Reporting System (VAERS).
*** Send your comments & questions to serge@thecrashcartrule.com ***
Although this episode may shock you it could also save your life and the lives of those you love.
I would highly recommend reading Dr. Ana's newsletter sub-stack listed here: https://anamihalceamdphd.substack.com/p/dark-field-microscopic-analysis-on
Alarming New Report from Working Group of Vaccine Analysis in Germany and Other Countries
https://anamihalceamdphd.substack.com/p/alarming-new-report-from-working
EVIDENCE OF SELF-ASSEMBLING STRUCTURES IN C19 INJECTION VIALS
https://www.bitchute.com/video/e9mvTko2Ts0T/
Computerized Thermographic Imaging and Live Blood Analysis post C19 injection
https://rumble.com/v1gzhzh-computerized-thermographic-imaging-and-live-blood-analysis-post-c19-injecti.html
EXCESS mortality (all-cause mortality) in selected high-vaccinated nations
Canadian data was not understandable and collected fully for meaningful interpretation but concentrate on the 0% horizontal line for the excess mortality graph
https://palexander.substack.com/p/excess-mortality-all-cause-mortality?s=r&utm_campaign=post&utm_medium=web